BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/11/2025 8:20:54 AM | Browse: 2 | Download: 1
 |
Received |
|
2025-08-29 03:28 |
|
Peer-Review Started |
|
2025-08-29 03:28 |
|
First Decision by Editorial Office Director |
|
2025-09-16 07:49 |
|
Return for Revision |
|
2025-09-16 07:49 |
|
Revised |
|
2025-09-17 14:17 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-22 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-22 08:52 |
|
Articles in Press |
|
2025-10-22 08:52 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-02 01:50 |
|
Publish the Manuscript Online |
|
2025-12-11 08:20 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Combining irreversible electroporation and immunotherapy for hepatocellular carcinoma: Reflections and directions for advancement
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Arunkumar Krishnan and Diptasree Mukherjee |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arunkumar Krishnan, Department of Oncology, Atrium Health Levine Cancer, 1021 Morehead Medical Drive, Suite 70100, Charlotte, NC 28204, United States. dr.arunkumar.krishnan@gmail.com |
| Key Words |
Irreversible electroporation; Anti-programmed death-1 therapy; Hepatocellular carcinoma; Tumor immunology; Immune checkpoint blockade; Murine cancer model; Translational oncology |
| Core Tip |
A recent study by Xing et al explored how combining a special tumor treatment called irreversible electroporation with a type of immunotherapy (anti-programmed death-1) can help the immune system fight liver cancer in mice. While the results are promising, the study requires clearer explanations of how and where samples were collected, more effective use of statistical methods, and a cautious interpretation of the findings. Future studies should use models more similar to human liver cancer and test long-term effects and safety to understand the treatment’s potential for patients. |
| Publish Date |
2025-12-11 08:20 |
| Citation |
Krishnan A, Mukherjee D. Combining irreversible electroporation and immunotherapy for hepatocellular carcinoma: Reflections and directions for advancement. World J Gastrointest Oncol 2025; 17(12): 113598 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i12/113598.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i12.113598 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
